Nutrition, Environmental Health, Disease and Injury Control Unit, School of Population Health, University of Queensland, Queensland, Australia.
Am J Clin Nutr. 2011 Mar;93(3):578-85. doi: 10.3945/ajcn.110.003913. Epub 2011 Jan 19.
The efficacy of vitamin A supplementation on diarrheal disease morbidity may reflect the divergent effects that supplementation has on pathogen-specific immune responses and pathogen-specific outcomes.
We examined how vitamin A supplementation modified associations between gut-cytokine immune responses and the resolution of different diarrheal pathogen infections.
Stools collected from 127 Mexican children who were 5-15 mo old and enrolled in a randomized, placebo-controlled vitamin A supplementation trial were screened for enteropathogenic Escherichia coli (EPEC), enterotoxigenic E. coli (ETEC), and Giardia lamblia. Fecal concentrations of interleukin (IL)-6, IL-8, IL-4, IL-5, IL-10, monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) were measured by using an enzyme-linked immunosorbent assay. Hazard models that incorporated categorized cytokine variables (ie, nondetectable, less than the median of detectable concentrations, and at least the median of detectable concentrations) were fit to the length of pathogen infections stratified by treatment group.
Vitamin A-supplemented children with fecal MCP-1 or IL-8 concentrations less than the median of detectable concentrations and IL-10 concentrations of at least median concentrations had longer durations of EPEC infection than did children in the placebo group. In supplemented children, detectable fecal TNF-α or IL-6 concentrations were associated with shorter ETEC infection durations, whereas MCP-1 concentrations of at least the median were associated with longer infection durations. Children in this group who had IL-4, IL-5, or IFN-γ concentrations of at least median detectable concentrations had shorter durations of G. lamblia infection.
The effect of supplementation on associations between fecal cytokine concentrations and pathogen infection resolution depends on the role of inflammatory immune responses in resolving specific pathogen infections.
维生素 A 补充剂对腹泻病发病率的疗效可能反映了补充剂对病原体特异性免疫反应和病原体特异性结果的不同影响。
我们研究了维生素 A 补充剂如何改变肠道细胞因子免疫反应与不同腹泻病原体感染消退之间的关系。
从 127 名 5-15 个月大的墨西哥儿童的粪便中采集样本,这些儿童参加了一项随机、安慰剂对照的维生素 A 补充剂试验,这些儿童的粪便样本用于筛查肠致病性大肠杆菌(EPEC)、肠毒性大肠杆菌(ETEC)和蓝氏贾第鞭毛虫。通过酶联免疫吸附试验测量粪便中白细胞介素(IL)-6、IL-8、IL-4、IL-5、IL-10、单核细胞趋化蛋白 1(MCP-1)、肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)的浓度。根据治疗组将病原体感染的长度分层,拟合包含分类细胞因子变量(即不可检测、低于可检测浓度中位数和至少等于可检测浓度中位数)的危险模型。
与安慰剂组相比,MCP-1 或 IL-8 浓度低于可检测浓度中位数且 IL-10 浓度至少等于中位数的维生素 A 补充儿童的 EPEC 感染持续时间更长。在补充组中,可检测的粪便 TNF-α或 IL-6 浓度与较短的 ETEC 感染持续时间相关,而至少达到中位数的 MCP-1 浓度与较长的感染持续时间相关。该组中 IL-4、IL-5 或 IFN-γ 浓度至少等于中位数的儿童的 G. lamblia 感染持续时间较短。
补充剂对粪便细胞因子浓度与病原体感染消退之间关系的影响取决于炎症免疫反应在解决特定病原体感染中的作用。